News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885 Results
Type
Article (48)
Company Profile (1)
Press Release (836)
Section
Business (206)
Career Advice (1)
Deals (46)
Drug Development (159)
FDA (20)
Job Trends (21)
News (420)
Policy (51)
Tag
Academia (3)
Accelerated approval (1)
Alliances (60)
Approvals (21)
Autoimmune disease (1)
Bankruptcy (1)
Best Places to Work (9)
Biotechnology (1)
Bladder cancer (18)
Brain cancer (3)
Cancer (31)
Career advice (1)
Cell therapy (3)
Clinical research (134)
Collaboration (1)
COVID-19 (9)
C-suite (1)
Data (11)
Diagnostics (1)
Drug discovery (1)
Earnings (96)
Events (137)
Executive appointments (1)
FDA (28)
Funding (2)
GLP-1 (2)
Government (1)
Healthcare (31)
Huntington's disease (1)
Immuno-oncology (1)
Infectious disease (9)
IPO (28)
Job creations (5)
Job search strategy (1)
Labor market (1)
Layoffs (11)
Legal (4)
Lung cancer (3)
Lymphoma (4)
MASH (1)
Medical device (6)
Medtech (6)
Mergers & acquisitions (19)
Metabolic disorders (1)
Neuroscience (1)
NextGen: Class of 2026 (3)
Non-profit (2)
Pancreatic cancer (2)
Patient recruitment (1)
People (57)
Phase 1 (39)
Phase 2 (74)
Phase 3 (48)
Pipeline (17)
Postmarket research (1)
Preclinical (10)
Prostate cancer (1)
Real estate (4)
Regulatory (55)
Research institute (5)
Series B (1)
Startups (2)
Vaccines (2)
Date
Last 7 days (1)
Last 30 days (11)
Last 365 days (49)
2026 (12)
2025 (45)
2024 (46)
2023 (32)
2022 (67)
2021 (82)
2020 (67)
2019 (37)
2018 (28)
2017 (21)
2016 (29)
2015 (32)
2014 (26)
2013 (70)
2012 (83)
2011 (85)
2010 (54)
Location
Africa (1)
Asia (16)
Australia (2)
California (50)
Canada (1)
Europe (26)
Florida (7)
Massachusetts (1)
Minnesota (1)
New York (1)
Pennsylvania (1)
Southern California (32)
Texas (5)
United States (65)
885 Results for "immunitybio inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle Invasive Bladder Cancer with Carcinoma In-Situ
January 15, 2026
·
8 min read
Press Releases
ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer
January 20, 2026
·
11 min read
Press Releases
ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas
February 2, 2026
·
9 min read
Press Releases
ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG
January 16, 2026
·
9 min read
Press Releases
ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”
December 29, 2025
·
3 min read
Press Releases
ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma
January 16, 2026
·
11 min read
Press Releases
ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer
January 14, 2026
·
9 min read
Press Releases
ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year
January 16, 2026
·
8 min read
Press Releases
NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security
January 13, 2026
·
7 min read
Press Releases
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
January 26, 2026
·
14 min read
1 of 89
Next
